Calamos Advisors LLC Abbott Laboratories Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

A detailed history of Calamos Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Calamos Advisors LLC holds 341,886 shares of ABT stock, worth $38.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
341,886
Previous 347,097 1.5%
Holding current value
$38.4 Million
Previous $36.1 Million 8.07%
% of portfolio
0.24%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$100.07 - $118.13 $521,464 - $615,575
-5,211 Reduced 1.5%
341,886 $39 Million
Q2 2024

Jul 25, 2024
SELL
$100.73 - $112.44 $893,978 - $997,905
-8,875 Reduced 2.49%
347,097 $36.1 Million
Q1 2024

May 08, 2024
SELL
$109.52 - $120.96 $689,537 - $761,564
-6,296 Reduced 1.74%
355,972 $40.5 Million
Q4 2023

Jan 31, 2024
SELL
$90.19 - $110.4 $277,695 - $339,921
-3,079 Reduced 0.84%
362,268 $39.9 Million
Q3 2023

Oct 25, 2023
BUY
$95.53 - $114.62 $47,765 - $57,310
500 Added 0.14%
365,347 $35.4 Million
Q2 2023

Jul 28, 2023
SELL
$100.78 - $112.29 $14 Million - $15.6 Million
-138,527 Reduced 27.52%
364,847 $39.8 Million
Q1 2023

May 03, 2023
SELL
$96.86 - $114.01 $3.34 Million - $3.93 Million
-34,500 Reduced 6.41%
503,374 $51 Million
Q4 2022

Jan 25, 2023
SELL
$95.06 - $111.52 $5.26 Million - $6.17 Million
-55,306 Reduced 9.32%
537,874 $0
Q3 2022

Oct 24, 2022
BUY
$96.76 - $112.03 $37,446 - $43,355
387 Added 0.07%
593,180 $57.4 Million
Q2 2022

Aug 01, 2022
BUY
$102.07 - $123.37 $3.74 Million - $4.52 Million
36,615 Added 6.58%
592,793 $64.4 Million
Q1 2022

May 03, 2022
BUY
$114.02 - $139.04 $5.47 Million - $6.67 Million
48,007 Added 9.45%
556,178 $65.8 Million
Q4 2021

Feb 01, 2022
BUY
$115.53 - $141.46 $1.4 Million - $1.71 Million
12,119 Added 2.44%
508,171 $71.5 Million
Q3 2021

Oct 26, 2021
BUY
$116.66 - $129.06 $9.55 Million - $10.6 Million
81,836 Added 19.76%
496,052 $58.6 Million
Q2 2021

Jul 22, 2021
BUY
$105.79 - $124.53 $6.6 Million - $7.77 Million
62,409 Added 17.74%
414,216 $48 Million
Q1 2021

Apr 12, 2021
BUY
$108.84 - $128.23 $713,010 - $840,034
6,551 Added 1.9%
351,807 $42.2 Million
Q4 2020

Jan 27, 2021
SELL
$105.0 - $114.42 $951,090 - $1.04 Million
-9,058 Reduced 2.56%
345,256 $37.8 Million
Q3 2020

Oct 26, 2020
SELL
$91.64 - $111.29 $1.72 Million - $2.09 Million
-18,810 Reduced 5.04%
354,314 $38.6 Million
Q2 2020

Jul 27, 2020
SELL
$76.57 - $98.0 $1.13 Million - $1.45 Million
-14,754 Reduced 3.8%
373,124 $34.1 Million
Q1 2020

Apr 28, 2020
SELL
$62.82 - $91.86 $3.09 Million - $4.52 Million
-49,155 Reduced 11.25%
387,878 $30.6 Million
Q4 2019

Jan 15, 2020
SELL
$78.51 - $87.4 $531,198 - $591,348
-6,766 Reduced 1.52%
437,033 $38 Million
Q3 2019

Oct 21, 2019
BUY
$81.84 - $88.74 $1.96 Million - $2.12 Million
23,936 Added 5.7%
443,799 $37.1 Million
Q2 2019

Aug 07, 2019
SELL
$72.88 - $85.0 $2.74 Million - $3.2 Million
-37,627 Reduced 8.22%
419,863 $35.3 Million
Q1 2019

Apr 12, 2019
BUY
$66.22 - $80.06 $127,738 - $154,435
1,929 Added 0.42%
457,490 $36.6 Million
Q4 2018

Jan 24, 2019
BUY
$65.56 - $74.27 $4.2 Million - $4.75 Million
64,022 Added 16.35%
455,561 $33 Million
Q3 2018

Oct 22, 2018
BUY
$60.81 - $73.36 $1.23 Million - $1.48 Million
20,152 Added 5.43%
391,539 $28.7 Million
Q2 2018

Jul 17, 2018
BUY
$57.57 - $63.54 $1.99 Million - $2.19 Million
34,493 Added 10.24%
371,387 $22.7 Million
Q1 2018

Apr 13, 2018
BUY
$56.27 - $63.62 $501,140 - $566,599
8,906 Added 2.72%
336,894 $20.2 Million
Q4 2017

Feb 13, 2018
SELL
$53.68 - $57.47 $761,021 - $814,752
-14,177 Reduced 4.14%
327,988 $18.7 Million
Q3 2017

Oct 25, 2017
BUY
$48.06 - $53.64 $152,926 - $170,682
3,182 Added 0.94%
342,165 $18.3 Million
Q2 2017

Aug 09, 2017
BUY
N/A
338,983
338,983 $16.5 Million

Others Institutions Holding ABT

# of Institutions
3,189
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email